First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 8.26 USD 1.85%
Updated: Apr 29, 2024

Zymeworks Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Revenue Peer Comparison

Comparables:
RPTX
FUSN
AUPH
EDT
SBFM

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
Sunshine Biopharma Inc
OTC:SBFM
Revenue
$24.1m
CAGR 3-Years
601%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zymeworks Inc's Revenue?
Revenue
76m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Revenue amounts to 76m USD.

What is Zymeworks Inc's Revenue growth rate?
Revenue CAGR 5Y
7%

Over the last year, the Revenue growth was -82%. The average annual Revenue growth rates for Zymeworks Inc have been 25% over the past three years , 7% over the past five years .